Biogen paring back research efforts; Will Chinese biotechs threaten US dominance?; What the new administration means for pharma ; and more

Welcome to the weekend! We saw a flurry of health-related news from Washington DC this week as the Trump administration officially began its transition. Let’s go over it. On the day he was sworn into ...